| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 23.307 | 36.823 | 32.286 | 15.718 | 4.537 | 7.516 | 3.626 | 2.608 | 250 | 0 |
| Total Income - EUR | 23.400 | 37.088 | 32.522 | 15.718 | 5.648 | 7.516 | 3.626 | 3.210 | 250 | 263 |
| Total Expenses - EUR | 19.808 | 33.849 | 13.777 | 23.466 | 4.848 | 6.608 | 2.635 | 105 | 266 | 26 |
| Gross Profit/Loss - EUR | 3.591 | 3.240 | 18.745 | -7.748 | 800 | 908 | 991 | 3.105 | -16 | 237 |
| Net Profit/Loss - EUR | 2.890 | 2.127 | 17.769 | -8.219 | 630 | 682 | 882 | 3.008 | -16 | 199 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Biohorizons S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 72.626 | 78.898 | 75.955 | 66.604 | 65.173 | 64.079 | 43.309 | 25.186 | 14.379 | 14.535 |
| Inventories | 51.949 | 46.485 | 47.435 | 23.518 | 20.032 | 13.420 | 10.797 | 10.831 | 10.798 | 10.738 |
| Receivables | 4.928 | 3.790 | 11.742 | 11.353 | 9.823 | 11.912 | 12.612 | 109 | 147 | 147 |
| Cash | 15.749 | 28.623 | 16.778 | 31.734 | 35.319 | 38.748 | 19.900 | 14.247 | 3.434 | 3.651 |
| Shareholders Funds | 16.052 | 15.889 | 15.620 | 7.114 | 6.976 | 7.527 | 7.725 | 10.757 | 24 | 223 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 56.574 | 63.009 | 60.335 | 59.490 | 58.197 | 56.552 | 35.584 | 14.429 | 14.354 | 14.312 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Biohorizons S.r.l.